Almstead Neil Gregory bought PTCT
October 3, 2025 · Form 4 insider transaction
Almstead Neil Gregory bought 51,558 shares of PTC Therapeutics, Inc. at $30.86 per share, a transaction worth $1.59M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,558
Price
$30.86
Total value
$1.59M
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after152,183
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024